Eli Kedar
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Immunology 79
- T-cell and B-cell Immunology 42
- Immunotherapy and Immune Responses 38
- Immune Cell Function and Interaction 21
- Hematology 14
- Hematopoietic Stem Cell Transplantation 14
- Co-authors
- Yechezkel Barenholz (17 shared papers)Benjamin Bonavida (12 shared papers)Manuel O. Landázuri (7 shared papers)Ilan Babai (8 shared papers)Sarit Samira (6 shared papers)John L. Fahey (5 shared papers)Aviva Joseph (6 shared papers)Shimon Slavin (14 shared papers)
- Journals
- Cancer Immunology Immunotherapy (11 papers)Journal of Immunological Methods (9 papers)The Journal of Immunology (8 papers)Transplantation (7 papers)Cellular Immunology (6 papers)
- Partner nations
- IsraelUnited StatesNetherlands
In The Last Decade
Eli Kedar
119 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 94
- Immunology 1.5k
- Biomaterials 289
- Pharmaceutical Science 114
- Hematology 181
- Oncology 203
Countries citing papers authored by Eli Kedar
This map shows the geographic impact of Eli Kedar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Kedar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Kedar more than expected).
Fields of papers citing papers by Eli Kedar
This network shows the impact of papers produced by Eli Kedar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Kedar. The network helps show where Eli Kedar may publish in the future.
Co-authors
The 25 scholars most cited alongside Eli Kedar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 208 | |
| 2 | 1974 | 105 | |
| 3 | 2005 | 93 | |
| 4 | 1985 | 79 | |
| 5 | 1992 | 65 | |
| 6 | 2003 | 65 | |
| 7 | 2001 | 63 | |
| 8 | 1997 | 61 | |
| 9 | 1999 | 57 | |
| 10 | 2001 | 57 | |
| 11 | 1996 | 54 | |
| 12 | 1982 | 53 | |
| 13 | 1994 | 50 | |
| 14 | 1983 | 47 | |
| 15 | 1991 | 46 | |
| 16 | Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2. | 1999 | 46 |
| 17 | 2003 | 46 | |
| 18 | 1971 | 41 | |
| 19 | 2000 | 41 | |
| 20 | 1974 | 40 |
About Eli Kedar
Eli Kedar is a scholar working on Immunology, Hematology, Biomaterials, Oncology and Pharmaceutical Science, having authored 120 papers that have together received 2.7k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (42 papers), Immunotherapy and Immune Responses (38 papers), Immune Cell Function and Interaction (21 papers), Hematopoietic Stem Cell Transplantation (14 papers), Nanoparticle-Based Drug Delivery (11 papers), Influenza Virus Research Studies (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Advanced Drug Delivery Systems (3 papers). The work is most often cited by research in Immunology (1.5k citations), Biomaterials (289 citations), Pharmaceutical Science (114 citations), Hematology (181 citations) and Oncology (203 citations). Eli Kedar has collaborated with scholars based in Israel, United States and Netherlands. Frequent co-authors include Yechezkel Barenholz, Benjamin Bonavida, Manuel O. Landázuri, Ilan Babai, Sarit Samira, John L. Fahey, Aviva Joseph, Shimon Slavin, Noam Emanuel and David Walter Weiss. Their work appears in journals such as Cancer Immunology Immunotherapy, Journal of Immunological Methods, The Journal of Immunology, Transplantation and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.